Among the promising proposed candidates are above-mentioned markers FOXF1 and c-KIT, which expression is decreased in the lungs of hyperoxia-exposed rodents and BPD patients alike [151, 183]. The gene discussed is FOXF1; the disease is bronchopulmonary dysplasia.